CN109790159B - 抗流感病毒嘧啶衍生物 - Google Patents
抗流感病毒嘧啶衍生物 Download PDFInfo
- Publication number
- CN109790159B CN109790159B CN201780054195.XA CN201780054195A CN109790159B CN 109790159 B CN109790159 B CN 109790159B CN 201780054195 A CN201780054195 A CN 201780054195A CN 109790159 B CN109790159 B CN 109790159B
- Authority
- CN
- China
- Prior art keywords
- compound
- pharmaceutically acceptable
- mmol
- acceptable salt
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910800902.6A CN110623958B (zh) | 2016-09-05 | 2017-09-05 | 抗流感病毒嘧啶衍生物 |
| CN201910800685.0A CN110627784B (zh) | 2016-09-05 | 2017-09-05 | 抗流感病毒嘧啶衍生物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2016108041013 | 2016-09-05 | ||
| CN201610804101 | 2016-09-05 | ||
| CN2016112387599 | 2016-12-28 | ||
| CN201611238759 | 2016-12-28 | ||
| PCT/CN2017/100461 WO2018041263A1 (zh) | 2016-09-05 | 2017-09-05 | 抗流感病毒嘧啶衍生物 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910800902.6A Division CN110623958B (zh) | 2016-09-05 | 2017-09-05 | 抗流感病毒嘧啶衍生物 |
| CN201910800685.0A Division CN110627784B (zh) | 2016-09-05 | 2017-09-05 | 抗流感病毒嘧啶衍生物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109790159A CN109790159A (zh) | 2019-05-21 |
| CN109790159B true CN109790159B (zh) | 2020-01-14 |
Family
ID=61300177
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780054195.XA Active CN109790159B (zh) | 2016-09-05 | 2017-09-05 | 抗流感病毒嘧啶衍生物 |
| CN201910800902.6A Active CN110623958B (zh) | 2016-09-05 | 2017-09-05 | 抗流感病毒嘧啶衍生物 |
| CN201910800685.0A Active CN110627784B (zh) | 2016-09-05 | 2017-09-05 | 抗流感病毒嘧啶衍生物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910800902.6A Active CN110623958B (zh) | 2016-09-05 | 2017-09-05 | 抗流感病毒嘧啶衍生物 |
| CN201910800685.0A Active CN110627784B (zh) | 2016-09-05 | 2017-09-05 | 抗流感病毒嘧啶衍生物 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US11136319B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3502112B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6838773B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102312088B1 (cg-RX-API-DMAC7.html) |
| CN (3) | CN109790159B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017320088B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3035680C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3502112T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL265166B (cg-RX-API-DMAC7.html) |
| MX (1) | MX394277B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2727772C1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201901894TA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018041263A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201901886B (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018033082A1 (en) | 2016-08-16 | 2018-02-22 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication, application methods and uses thereof |
| US10647693B2 (en) | 2016-08-30 | 2020-05-12 | North & South Brother Pharmacy Investment Company Limited | Inhibitors of influenza virus replication, application methods and uses thereof |
| MX394277B (es) * | 2016-09-05 | 2025-03-24 | Guangdong Raynovent Biotech Co Ltd | Derivados de pirimidina contra virus de la influenza |
| CN108218873B (zh) | 2016-12-15 | 2020-07-07 | 广东东阳光药业有限公司 | 流感病毒复制抑制剂及其用途 |
| US11098042B2 (en) | 2017-01-05 | 2021-08-24 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication and uses thereof |
| US10927118B2 (en) | 2017-03-02 | 2021-02-23 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication and uses thereof |
| EP3763713A4 (en) * | 2018-03-05 | 2021-11-24 | Guangdong Raynovent Biotech Co., Ltd. | CRYSTAL FORM AND SALT FORM OF A PYRIDOIMIDAZOLE COMPOUND AND THE METHOD FOR MANUFACTURING IT |
| CN110590768B (zh) * | 2018-06-13 | 2021-02-26 | 银杏树药业(苏州)有限公司 | 杂环化合物、其组合物及其作为抗流感病毒药物的应用 |
| CN114127068B (zh) * | 2019-07-22 | 2024-05-28 | 广东众生睿创生物科技有限公司 | 嘧啶衍生物的优势盐型及其晶型 |
| WO2021047437A1 (zh) * | 2019-09-10 | 2021-03-18 | 广东众生睿创生物科技有限公司 | 一种用于治疗病毒性感冒的药物组合物及其制剂 |
| CN111454166B (zh) * | 2019-12-30 | 2021-02-26 | 广东莱佛士制药技术有限公司 | 制备(2s,3s)-3-氨基-二环[2.2.2]辛烷-2-甲酸酯的方法 |
| CN113116899B (zh) * | 2020-03-06 | 2022-12-20 | 广东众生睿创生物科技有限公司 | 一种用于治疗流感的药物组合物及含有该药物组合物的制剂 |
| WO2022089261A1 (zh) * | 2020-10-29 | 2022-05-05 | 广东众生睿创生物科技有限公司 | 一种嘧啶衍生物的晶型及其制备方法 |
| CN114569562B (zh) * | 2020-12-01 | 2025-07-29 | 南通诺泰生物医药技术有限公司 | 一种抗流感病毒的药物组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101903354B1 (ko) | 2009-06-17 | 2018-10-04 | 버텍스 파마슈티칼스 인코포레이티드 | 인플루엔자 바이러스 복제의 억제제 |
| KR20140014110A (ko) * | 2010-12-16 | 2014-02-05 | 버텍스 파마슈티칼스 인코포레이티드 | 인플루엔자 바이러스 복제의 억제제 |
| US20130102600A1 (en) * | 2011-10-21 | 2013-04-25 | F. Hoffmann-La Roche Ltd | Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| MX381488B (es) * | 2014-08-08 | 2025-03-12 | Janssen Sciences Ireland Uc | Indoles para su uso en la infección por el virus de la gripe. |
| RU2737190C2 (ru) * | 2015-12-09 | 2020-11-25 | Саншайн Лейк Фарма Ко., Лтд. | Ингибиторы репликации вируса гриппа, способы их применения и использование |
| WO2017133657A1 (en) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza |
| WO2017133670A1 (en) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza |
| WO2018033082A1 (en) | 2016-08-16 | 2018-02-22 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication, application methods and uses thereof |
| MX394277B (es) * | 2016-09-05 | 2025-03-24 | Guangdong Raynovent Biotech Co Ltd | Derivados de pirimidina contra virus de la influenza |
| EP3763713A4 (en) * | 2018-03-05 | 2021-11-24 | Guangdong Raynovent Biotech Co., Ltd. | CRYSTAL FORM AND SALT FORM OF A PYRIDOIMIDAZOLE COMPOUND AND THE METHOD FOR MANUFACTURING IT |
| CN114127068B (zh) * | 2019-07-22 | 2024-05-28 | 广东众生睿创生物科技有限公司 | 嘧啶衍生物的优势盐型及其晶型 |
-
2017
- 2017-09-05 MX MX2019002541A patent/MX394277B/es unknown
- 2017-09-05 US US16/330,353 patent/US11136319B2/en active Active
- 2017-09-05 WO PCT/CN2017/100461 patent/WO2018041263A1/zh not_active Ceased
- 2017-09-05 DK DK17845565.5T patent/DK3502112T3/da active
- 2017-09-05 CA CA3035680A patent/CA3035680C/en active Active
- 2017-09-05 CN CN201780054195.XA patent/CN109790159B/zh active Active
- 2017-09-05 KR KR1020197009275A patent/KR102312088B1/ko active Active
- 2017-09-05 CN CN201910800902.6A patent/CN110623958B/zh active Active
- 2017-09-05 RU RU2019109246A patent/RU2727772C1/ru active
- 2017-09-05 JP JP2019512638A patent/JP6838773B2/ja active Active
- 2017-09-05 SG SG11201901894TA patent/SG11201901894TA/en unknown
- 2017-09-05 CN CN201910800685.0A patent/CN110627784B/zh active Active
- 2017-09-05 EP EP17845565.5A patent/EP3502112B1/en active Active
- 2017-09-05 AU AU2017320088A patent/AU2017320088B2/en active Active
-
2019
- 2019-03-04 IL IL265166A patent/IL265166B/en unknown
- 2019-03-27 ZA ZA2019/01886A patent/ZA201901886B/en unknown
-
2021
- 2021-08-24 US US17/410,801 patent/US11725009B2/en active Active
-
2023
- 2023-06-19 US US18/337,329 patent/US12319692B2/en active Active
-
2025
- 2025-04-28 US US19/191,976 patent/US20250250275A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109790159B (zh) | 抗流感病毒嘧啶衍生物 | |
| CN110944989B (zh) | 作为egfr激酶抑制剂的芳基磷氧化合物 | |
| JP2019529386A5 (cg-RX-API-DMAC7.html) | ||
| CN109071538B (zh) | 作为ask1抑制剂的吡啶衍生物及其制备方法和应用 | |
| CN107531711B (zh) | Janus激酶抑制剂 | |
| CN107922349B (zh) | 作为fgfr和vegfr抑制剂的乙烯基化合物 | |
| WO2018192493A1 (zh) | 作为pcsk9抑制剂的哌啶类化合物 | |
| WO2018233648A1 (zh) | 作为TLR8激动剂的异噻唑并[4,3-d]嘧啶-5,7-二胺衍生物 | |
| CN110461855B (zh) | 氮杂环丁烷衍生物 | |
| CN110225781B (zh) | 噻唑衍生物及其应用 | |
| WO2018036470A1 (zh) | 作为pde4抑制剂的并环类化合物 | |
| CN109803951B (zh) | 作为cccDNA抑制剂的磺酰胺类化合物 | |
| HK40003826A (en) | Anti-influenza virus pyrimidine derivatives | |
| HK40003826B (en) | Anti-influenza virus pyrimidine derivatives | |
| US10851112B2 (en) | Anti-HCMV virus compound | |
| BR112019004420B1 (pt) | Composição farmacêutica | |
| HK40009263B (zh) | 氮杂环丁烷衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 3406a, jinzhonghuan international business building, 3037 Jintian Road, Fu'an community, Futian street, Futian District, Shenzhen City, Guangdong Province Applicant after: Guangdong Zhongsheng Ruichuang Biotechnology Co., Ltd. Address before: Room 1701-1705, Main Building, Rongyi Building, No. 5 Information Road, Songshan Lake High-tech Industrial Development Zone, Dongguan City, Guangdong Province Applicant before: Guangdong Zhongsheng Ruichuang Biotechnology Co., Ltd. |
|
| CB02 | Change of applicant information | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40003826 Country of ref document: HK |